October 2017

Should glaucoma patients avoid glucosamine?

A new clinical study shows that taking glucosamine sulfate 750 mg three times daily for 3 months can increase intraocular pressure (IOP) in some people. About 34% of patients who took this dose of glucosamine sulfate experienced a clinically meaningful increase in IOP compared to only about 13% of patients taking placebo. To be on the safe side, patients with severe glaucoma should avoid glucosamine. Patients with mild-to-moderate glaucoma should be monitored for changes in IOP if they start taking glucosamine. Recommend checking IOP within 3 months of starting glucosamine. If IOP increases, glucosamine may need to be discontinued. For more details about glucosamine, review our complete scientific monograph.

The information in this brief report is intended for informational purposes only, and is meant to help users better understand health concerns. This information should not be interpreted as specific medical advice. Users should consult with a qualified healthcare provider for specific questions regarding therapies, diagnosis and/or health conditions, prior to making therapeutic decisions. Copyright © 2024 NatMed. Commercial distribution or reproduction prohibited. NatMed is the leading provider of high-quality, evidence-based, clinically-relevant information on natural medicine, dietary supplements, herbs, vitamins, minerals, functional foods, diets, complementary practices, CAM modalities, exercises and medical conditions. Monograph sections include interactions with herbs, drugs, foods and labs, contraindications, depletions, dosing, toxicology, adverse effects, pregnancy and lactation data, synonyms, safety and effectiveness.